accountAcura Pharmaceuticals' idea of bringing to market an addiction-resistant pain medication that it had been developing jointly with King Pharmaceuticals (NYSE: KG) CAPS member 6cents says whatever else Acura may have going for it, there's no catalyst right...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Hidden Stocks for High Returns
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account